| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Lieberman JA | |
| Bilder RM | |||
| Lipschutz-Broch L | |||
| Turkel E | |||
| P433 | issue | 4 | |
| P921 | main subject | neuropsychology | Q3872 |
| P304 | page(s) | 353-366 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Psychopharmacology Bulletin | Q20182701 |
| P1476 | title | Antipsychotic medication effects on neuropsychological functions | |
| P478 | volume | 28 |
| Q42137909 | Adjunctive memantine therapy for cognitive impairment in chronic schizophrenia: a placebo-controlled pilot study |
| Q40445523 | Antipsychotics in older patients. A safety perspective |
| Q58098800 | Childhood Trauma and Neurocognition in Adults With Psychotic Disorders: A Systematic Review and Meta-analysis |
| Q91938842 | Cognition and violent behavior in psychotic disorders: A nationwide case-control study |
| Q35991098 | Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study |
| Q36381682 | Comparison of Visuospatial and Verbal Abilities in First Psychotic Episode of Schizophrenia Spectrum Disorder: Impact on Global Functioning and Quality of Life. |
| Q37075965 | Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia? |
| Q33888153 | Effect of second-generation antipsychotics on cognition: current issues and future challenges |
| Q39292622 | Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. |
| Q34415896 | Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness |
| Q36940031 | Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition |
| Q33877837 | Measuring neuropsychological change in schizophrenia with novel antipsychotic medications |
| Q30438103 | Mild expression differences of MECP2 influencing aggressive social behavior |
| Q40592040 | Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? |
| Q36935081 | The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia. |
| Q33921935 | The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia |
Search more.